强强联合,持久获益——系统性治疗失败的MSI-H/dMMR转移性结直肠癌的免疫联合治疗

    Strong Combination, Long-Lasting Benefit: Immunotherapy Combination for MSI-H/dMMR Metastatic Colorectal Cancer That Has Failed Systemic Treatment

    /

    返回文章
    返回